| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
25,896.45
|
|
Change (%)
|
-175.50 (-0.67%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
25,775.60
-
26,120.00
|
|
52-Week Range (RS)
|
25,164.00
-
31,650.00
|
|
Beta (1 Year)
|
0.28
|
|
|
|
|
|
| Index Details |
| BSE 500, BSE 200, BSE HC, BSE DOLLEX, BSE Midcap |
| News |
|
Corporate Details |
| Volumes spurt at Aster DM Quality Care Ltd counter |
| Abbott India Ltd down for fifth straight session |
| Abbott India standalone net profit rises 17.13% in the June 2026 quarter |
| Abbott India to announce Quarterly Result |
| Abbott India Ltd gains for fifth session |
| Abbott India Ltd drops for fifth straight session |
| Abbott India to convene AGM |
| Board of Abbott India recommends final dividend |
| Board of Abbott India recommends special dividend |
| Abbott India standalone net profit rises 7.60% in the March 2026 quarter |
|
|
|
| Incoporation Year : 1944 |
| Chairman : Munir Shaikh |
| Ownership Group : MNC Asc-Abbott |
| Sector : MAN |
| Industry : Pharmaceuticals - Multinational |
| Registered Office |
Abbott India Ltd Unit No 3 Corporate Park, Sion Trombay Road Chembur, Mumbai, Maharashtra-400071 |
Phone:91-22-67978888/50461000/2000/1119 Fax:91-22-50169400 |
| E-Mail : investorrelations.india@abbott.com; webmaster@abbo |
| URL : http://www.abbott.co.in |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
31-Aug-2026 |
25856.10 |
0.16 |
| 1Month |
07-Aug-2026 |
27780.40 |
-6.78 |
| 3Month |
08-Jun-2026 |
25792.95 |
0.40 |
| 6Month |
09-Mar-2026 |
27158.55 |
-4.65 |
| 1Year |
08-Sep-2025 |
30979.70 |
-16.41 |
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| SBI Large & Midcap Fund |
2.02 |
856.24 |
| AXIS Midcap Fund |
1.32 |
452.72 |
| Canara Robeco Large and Mid Cap Fund |
1.41 |
368.00 |
| Nippon India Multi Cap Fund |
0.63 |
352.15 |
| Nippon India Pharma Fund |
2.24 |
207.95 |
|
|
|
| Groups : Pharmaceuticals - Multinational |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Glaxosmithkline Pharmaceuticals Ltd |
2,956.95 |
-0.06 |
3,121.10 |
2,088.00 |
50,092.52 |
| Pfizer Ltd |
4,594.25 |
-0.42 |
5,561.55 |
4,361.00 |
21,017.65 |
| Astrazeneca Pharma India Ltd |
6,853.70 |
-1.11 |
9,850.00 |
6,815.30 |
17,134.25 |
| Sanofi Consumer Healthcare India Ltd |
4,114.40 |
-2.49 |
5,394.00 |
3,950.50 |
9,475.72 |
| Procter & Gamble Health Ltd |
5,673.90 |
0.28 |
6,955.00 |
4,699.70 |
9,418.32 |
|
|
|
|